Media Coverage
Filter
-
- All Categories
- Brain Health
- Cancers
- Cell Dynamics
- Computational Biology
- COVID-19
- Disease
- Healthspan
- Healthy Aging
- Infectious Disease
- Microbiome
- Pregnancy Health
- Scientific Wellness
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
Is AI the Cancer-Fighting Tool We’ve Been Waiting For?
As AI and new imaging tools give researchers vast amounts of data on tumors, they are winning some battles against cancer. ISB President Dr. Jim Heath was interviewed for this extensively reported feature story for Newsweek Magazine.
A Gut Feeling About Precision Medicine
ISB Associate Professor Dr. Sean Gibbons spoke with Mark O. Martin from the University of Puget Sound. Gibbons talked about how the study of host-associated microbial communities gives us insights into evolution, ecology and human health.
Institute for Systems Biology and NED Biosystems Will Collaborate to Reverse Cancer Onset
ISB and NED Biosystems will collaborate on an intriguing clinical trial that aims to use a cocktail of several marketed medications at low doses to reverse cancer’s onset or regrowth. ISB Co-founder Lee Hood and NED Biosystems founder and CEO Rebecca Lambert announced the deal.
Is This Microbiome Startup Selling a Wellness Fantasy?
Sean Gibbons was quoted in this Bloomberg Businessweek story examining Viome and the often questionable microbiome-wellness startup space.
T Cell Discovery Unlocks Potential for Crafting Tailored Immune Responses
This story published by Inside Precision Medicine covers ISB research showing that the different disease-fighting functions of distinct T cells are determined by the genetically encoded T-cell receptor (TCR) sequence that are unique to those cells. The findings are promising for developing custom immune responses to specific antigens.
Adding lifestyle coaching to treatment decreases cognitive decline in early Alzheimer’s
McKnights Senior Living published a news story detailing results from the ISB-led Coaching for Cognition in Alzheimer’s (COCOA) trial showing that supplementing the standard of care for early-stage Alzheimer’s disease with lifestyle coaching leads to less cognitive decline.
Computer Model Identifies Which Species Are Important in a Healthy Microbiome
ISB researchers collaborated on an international research project that found a way to determine which species in the gut are important and how they interact to create a healthy microbiome.
A systems biology perspective on the gut microbiome
ISB Associate Professor Dr. Sean Gibbons was a guest on the ISAPP Science, Microbes & Health podcast. In this episode, Gibbons talked about exploring and manipulating the complex ecology of the microbiome with the aim of engineering outputs of this system, as well as the utility of AI in microbiome science and how the microbiome will play a role in personalized medicine in the future, including in the delivery of probiotics and prebiotics.